Topic Hub

Pt 141 — Access & Coverage

3 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

3articles

27keywords mapped

2026-05-26latest review

Explore

Pt 141 — Access & Coverage library

Showing 3 of 3 clinical reviews.

Access2026-05-26

PT-141 (Bremelanotide) Medicare Advantage Coverage: What You Need to Know in 2026

Find out whether Medicare Advantage plans cover PT-141 (bremelanotide/Vyleesi), what you can expect to pay, and how to access this medication affordably through compounding pharmacies, manufacturer programs, and alternative coverage pathways.

Read clinical review

Access2026-05-25

PT-141 (Bremelanotide) Medicare Part D Coverage: What's Actually Covered in 2026

Medicare Part D does not cover PT-141 (bremelanotide/Vyleesi) for hypoactive sexual desire disorder. Learn why, what it costs out of pocket, and how to access it affordably through compounding pharmacies, manufacturer programs, and alternative coverage routes.

Read clinical review

Clinical Reviews2026-05-26

PT-141 (Bremelanotide) Patient Assistance for Low-Income Patients

How to access PT-141 (bremelanotide) at reduced or no cost through manufacturer programs, compounding pharmacies, and patient assistance options in 2026.

Read clinical review